Feinstein Kean Healthcare (FKH), an Ogilvy company, is a strategy and communication firm, headquartered in Cambridge, MA, with offices in New Jersey, and Washington, DC. Their clients range from global, Fortune 500 companies to leading research & academic institutions, to professional & patient groups - most of which are at the center of major shifts taking place in health care.
They work in all areas of health, including with large, global & emerging pharmaceutical/biopharmaceutical, health IT, diagnostic & device, contract research, health management & wellness, food & nutrition, tools & services companies, as well as government agencies, academic medicine, industry, professional & advocacy organizations, payers and hospitals.
Their expertise spans virtually all major disease categories & stages of development & commercialization, as well as advanced & emerging areas of innovation, such as genomics, proteomics, nanotechnology, & new informatics-based solutions applied to improve the productivity of research, clinical decision-making & patient compliance, or to measure & manage outcomes. This uniquely comprehensive experience, built during 20+ years of service to the sector, informs their work on strategy, brand development, marketing, public affairs, media & advocacy relations, patient & professional education, corporate, pipeline & product communications, social media research & engagement, as well as issues management and risk communication.